MEDI
Medimmune, Inc.
Biotechnology company focused on innovative therapies and vaccines; acquired by AstraZeneca in 2007 and brand retired in 2019.
CUSIP: 584699102HealthcareUS1 holder
Medimmune, Inc.
Biotechnology company focused on innovative therapies and vaccines; acquired by AstraZeneca in 2007 and brand retired in 2019.
No Schedule 13D or 13G filings recorded.